✦ LIBER ✦

Treatment of operable breast cancer in the elderly: a randomised clinical trial EORTC 10851 comparing tamoxifen alone with modified radical mastectomy

✍ Scribed by I.S Fentiman; M.-R Christiaens; R Paridaens; A Van Geel; E Rutgers; J Berner; G de Keizer; J Wildiers; M Nagadowska; C Legrand; P Therasse

Book ID: 117659210
Publisher: Elsevier Science
Year: 2003
Tongue: English
Weight: 173 KB
Volume: 39
Category: Article
ISSN: 0959-8049
DOI: 10.1016/s0959-8049(02)00673-1

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Treatment of operable breast cancer in t

Treatment of operable breast cancer in the elderly: a randomised clinical trial EORTC 10850 comparing modified radical mastectomy with tumorectomy plus tamoxifen

✍ I.S Fentiman; J van Zijl; I Karydas; M.A Chaudary; R Margreiter; C Legrand; P Th 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 181 KB

A randomised trial comparing tamoxifen v

A randomised trial comparing tamoxifen vs. surgery in patients over the age of 70 with operable breast cancer - Final results after 28 years of follow-up

✍ J.-C. Gazet; R. Sutcliffe 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 345 KB

Reanalysis and Results after 12 Years of

Reanalysis and Results after 12 Years of Follow-up in a Randomized Clinical Trial Comparing Total Mastectomy with Lumpectomy with or without Irradiation in the Treatment of Breast Cancer

✍ Fisher, Bernard; Anderson, Stewart; Redmond, Carol K.; Wolmark, Norman; Wickerha 📂 Article 📅 1995 🏛 Massachusetts Medical Society 🌐 English ⚖ 132 KB

NSABP Protocol B-06: A randomized clinic

NSABP Protocol B-06: A randomized clinical trial comparing total mastectomy with lumpectomy with or without irradiation in the treatment of breast cancer — Results after 15 years of follow-up

✍ D.L. Wickerham; S.A. Anderson; B. Fisher; R. Margolese; T. Mamounas; N. Wolmark 📂 Article 📅 1998 🏛 Elsevier Science 🌐 English ⚖ 153 KB

First results of a randomized phase III

First results of a randomized phase III trial comparing exemestane versus tamoxifen as first-line hormone therapy (HT) for postmenopausal women with metastatic breast cancer (MBC) — EORTC 10951 in collaboration with the exemestane working group and NCIC Clinical Trials Group

✍ R Paridaens; P Therasse; L Dirix; L Beex; M.J Piccart; D Cameron; T Cufer; K Roo 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 172 KB